Stephane P.
- Country
- France
- Department
- Centre Hospitalier Universitaire d' Orleans, Service de Pédiatrie
Research Overview
- Long-Term Safety and Efficacy of Intrathecal Cebsulfase Alfa in Pediatric Patients with Late Metachromatic Leukodystrophy: An Extension of Study HGT-MLD-070
- Long-Term Safety Evaluation of Teplizumab in Pediatric and Adolescent Patients with Recent-Onset Type 1 Diabetes Mellitus: An Extension of Study PRV-031-001
Data & Insights
Has run more than one trial at 2 of 27 partner sites.
Specializations
Metabolic Disorders
The investigator specializes in the study of Type 1 Diabetes Mellitus, focusing on innovative therapeutic approaches for disease management and treatment.
- Autoimmune diabetes research
- Long-term disease monitoring
- Novel therapeutic interventions
Particular emphasis is placed on evaluating emerging treatments for recent-onset diabetes patients.
Neurological Disorders
The investigator conducts research in Metachromatic Leukodystrophy (MLD), with a focus on pediatric applications and enzyme replacement therapies.
- Lysosomal storage disorders
- Intrathecal therapeutic delivery
- Pediatric neurological conditions
Their work encompasses long-term therapeutic monitoring in children with rare genetic disorders.
Therapeutic Expertise
The investigator focuses on enzyme replacement therapies and immunological interventions across multiple disease areas.
- Long-term safety assessment
- Therapeutic monitoring
- Extended follow-up studies
Their research emphasizes the evaluation of treatment safety and efficacy in chronic conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.